Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Case Reports in Immunology · 04.06.2021 · 2021 · 1-5
DOI: 10.1155/2021/6624682 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Immunology, erschienen am 04.06.2021. Verfasst von Barbara Steinlechner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, V…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin therapy. A low platelet count of 61 G/L was accompanied by the presence of circulating HIT antibodies 12 days after ECMO initiation. Replacement of the ECMO system including cannulas resulted in the normalization of the platelet count. However, the clinical situation did not improve, and the patient died 9 days later. Careful consideration of anticoagulant therapy and ECMO circuit, as well as routine HIT antibody testing, may prevent a fatal course in ECMO-supported COVID-19 patients.
Autor:innen und Institutionen
- Division of Cardiothoracic and Vascular Anesthesia, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria.
- Division of Hematology and Hemostaseology, Department of Medicine I, Medical University Vienna, Vienna, Austria.
- Division of General Anesthesia and Intensive Care Medicine, Department of Anesthesia, Intensive Care Medicine and Pain Medicine, Medical University Vienna, Vienna, Austria.
ORCID-Profile: Barbara Steinlechner
Zitieren
APA
Steinlechner, B., Kargl, G., Schlömmer, C., Holaubek, C., Scheriau, G., Eichinger, S., Gratz, J., & Rössler, B. (2021). Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?. Case Reports in Immunology, 2021, 1-5. https://doi.org/10.1155/2021/6624682
Vancouver
Steinlechner B, Kargl G, Schlömmer C, Holaubek C, Scheriau G, Eichinger S, et al. Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?. Case Reports in Immunology. 2021;2021:1-5. doi:10.1155/2021/6624682
BibTeX
@article{Steinlechner2021,
author = {Steinlechner, Barbara and Kargl, Gabriele and Schlömmer, Christine and Holaubek, Caroline and Scheriau, Georg and Eichinger, Sabine and Gratz, Johannes and Rössler, Bernhard},
title = {Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?},
journal = {Case Reports in Immunology},
year = {2021},
volume = {2021},
pages = {1--5},
doi = {10.1155/2021/6624682}
}
EUVIMED